Stock Track | Harrow Health Plummets 19.59% in Pre-Market on Earnings Miss and Below-Estimate 2026 Revenue Guidance

Stock Track03-03

Harrow Health Inc. (HROW) experienced a significant pre-market plummet of 19.59% on Tuesday, as the stock opened sharply lower following the release of its latest financial results.

The sharp decline was driven by the company's fourth-quarter earnings report, which revealed earnings per share of $0.17, significantly missing the analyst consensus estimate of $0.38. Furthermore, the ophthalmic drugmaker issued its fiscal 2026 revenue guidance in the range of $350 million to $365 million, which fell below the average analyst estimate of approximately $386 million.

This combination of an earnings shortfall and weaker-than-anticipated forward outlook prompted a sell-off, with the stock extending losses from the previous trading session and underperforming the broader healthcare sector during the pre-market session.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1194777618?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-03 22:45","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194777618","market":"us","top_or_hot":-1,"title":"Stock Track | Harrow Health Plummets 19.59% in Pre-Market on Earnings Miss and Below-Estimate 2026 Revenue Guidance","media":"Stock Track","content":"<p>Harrow Health Inc. (HROW) experienced a significant pre-market plummet of 19.59% on Tuesday, as the stock opened sharply lower following the release of its latest financial results.</p><p>The sharp decline was driven by the company's fourth-quarter earnings report, which revealed earnings per share of $0.17, significantly missing the analyst consensus estimate of $0.38. Furthermore, the ophthalmic drugmaker issued its fiscal 2026 revenue guidance in the range of $350 million to $365 million, which fell below the average analyst estimate of approximately $386 million.</p><p>This combination of an earnings shortfall and weaker-than-anticipated forward outlook prompted a sell-off, with the stock extending losses from the previous trading session and underperforming the broader healthcare sector during the pre-market session.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Harrow Health Plummets 19.59% in Pre-Market on Earnings Miss and Below-Estimate 2026 Revenue Guidance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Harrow Health Plummets 19.59% in Pre-Market on Earnings Miss and Below-Estimate 2026 Revenue Guidance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2026-03-03 22:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Harrow Health Inc. (HROW) experienced a significant pre-market plummet of 19.59% on Tuesday, as the stock opened sharply lower following the release of its latest financial results.</p><p>The sharp decline was driven by the company's fourth-quarter earnings report, which revealed earnings per share of $0.17, significantly missing the analyst consensus estimate of $0.38. Furthermore, the ophthalmic drugmaker issued its fiscal 2026 revenue guidance in the range of $350 million to $365 million, which fell below the average analyst estimate of approximately $386 million.</p><p>This combination of an earnings shortfall and weaker-than-anticipated forward outlook prompted a sell-off, with the stock extending losses from the previous trading session and underperforming the broader healthcare sector during the pre-market session.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"HROW","symbol_name":"Harrow Health Inc","start_time":0,"source_url":"","article_id":"1194777618","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194777618","pubTimestamp":1772549157,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Harrow Health Inc. (HROW) experienced a significant pre-market plummet of 19.59% on Tuesday, as the stock opened sharply lower following the release of its latest financial results.The sharp decline...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"HROW":"Harrow Health Inc"},"translate_title":"个股追踪|Harrow Health盘前暴跌19.59%，因盈利不及预期且2026年营收指引低于预期","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"HROW":1},"content_text":"Harrow Health Inc. (HROW) experienced a significant pre-market plummet of 19.59% on Tuesday, as the stock opened sharply lower following the release of its latest financial results.The sharp decline was driven by the company's fourth-quarter earnings report, which revealed earnings per share of $0.17, significantly missing the analyst consensus estimate of $0.38. Furthermore, the ophthalmic drugmaker issued its fiscal 2026 revenue guidance in the range of $350 million to $365 million, which fell below the average analyst estimate of approximately $386 million.This combination of an earnings shortfall and weaker-than-anticipated forward outlook prompted a sell-off, with the stock extending losses from the previous trading session and underperforming the broader healthcare sector during the pre-market session.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1194777618","isCrawlerRequest":true}